S2CID 86254068
Is there evidence linking IGF-1 signaling to cancer risk
Aqua (water), Glycolic Acid, Rosa Damascena Flower Water, Centaurea Cyanus Flower Water, Aloe Barbadensis Leaf Water, Propanediol, Glycerin, Triethanolamine, Aminomethyl Propanol, Panax Ginseng Root Extract, Tasmannia Lanceolata Fruit/leaf Extract, Aspartic Acid, Alanine, Glycine, Serine, Valine, Isoleucine, Proline, Threonine, Histidine, Phenylalanine, Glutamic Acid, Arginine, Pca, Sodium Pca, Sodium Lactate, Fructose, Glucose, Sucrose, Urea, Hexyl Nicotinate, Dextrin, Citric Acid, Polysorbate 20, Gellan Gum, Trisodium Ethylenediamine Disuccinate, Sodium Chloride, Hexylene Glycol, Potassium Sorbate, Sodium Benzoate, 1,2-hexanediol, Caprylyl Glycol
For instance, a study published in the Journal of Clinical Endocrinology & Metabolism indicated potential benefits of weight loss medications, including GLP-1 agonists, on sexual function and satisfaction due to hormonal and psychological improvements (Griffiths et al., 2020)
A limitation for neuropathy benefits is that many studies used intravenous or intramuscular treatment
Inhibition of topoisomerases by metal thiosemicarbazone complexes